23
Participants
Start Date
June 30, 2011
Primary Completion Date
October 31, 2013
oxytocin
Patients will be randomized to receive intranasal oxytocin or placebo in a dose escalation paradigm with three dose cohorts: 24IU, 48IU and 72IU of intranasal oxytocin twice daily for 1 week
Saline Nasal Mist
Placebo arm wil receive saline nasal mist sprays matched in number to oxytocin dose cohorts
Cognitive Neurology and Alzheimer Research Centre, London
Consortium of Canadian Centres for Clinical Cognitive Research
OTHER
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
OTHER